Estimating time-to-event from longitudinal ordinal data using random-effects Markov models: application to multiple sclerosis progression.
Longitudinal ordinal data are common in many scientific studies, including those of multiple sclerosis (MS), and are frequently modeled using Markov dependency. Several authors have proposed random-effects Markov models to account for heterogeneity in the population. In this paper, we go one step further and study prediction based on random-effects Markov models. In particular, we show how to calculate the probabilities of future events and confidence intervals for those probabilities, given observed data on the ordinal outcome and a set of covariates, and how to update them over time. We discuss the usefulness of depicting these probabilities for visualization and interpretation of model results and illustrate our method using data from a phase III clinical trial that evaluated the utility of interferon beta-1a (trademark Avonex) to MS patients of type relapsing-remitting.
Mandel
Micha
M
Department of Statistics, The Hebrew University of Jerusalem, Mount Scopus, Jerusalem, Israel. msmic@mscc.huji.ac.il
Betensky
Rebecca A
RA
D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D016001:Confidence Intervals; D004185:Disability Evaluation; D018450:Disease Progression; D006801:Humans; D000068556:Interferon beta-1a; D016899:Interferon-beta / Q000627:therapeutic use; D008137:Longitudinal Studies; D008390:Markov Chains; D008954:Models, Biological; D020529:Multiple Sclerosis, Relapsing-Remitting / Q000188:drug therapy / Q000503:physiopathology*; D012008:Recurrence; D016896:Treatment Outcome; D014894:Weights and Measures
D016899:Interferon-beta; D000068556:Interferon beta-1a